Isofraxidin Alleviates Myocardial Infarction Through NLRP3 Inflammasome Inhibition
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Isofraxidin Alleviates Myocardial Infarction Through NLRP3 Inflammasome Inhibition
Authors
Keywords
-
Journal
INFLAMMATION
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-01-09
DOI
10.1007/s10753-019-01158-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- cGAS in action: Expanding roles in immunity and inflammation
- (2019) Andrea Ablasser et al. SCIENCE
- Isofraxidin attenuates IL‐1β‐induced inflammatory response in human nucleus pulposus cells
- (2019) Xiaoqiang Su et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Irisin exerts a therapeutic effect against myocardial infarction via promoting angiogenesis
- (2019) Qiao Liao et al. ACTA PHARMACOLOGICA SINICA
- Role of NLRP3 Inflammasome in Cardiac Inflammation and Remodeling after Myocardial Infarction
- (2019) Masafumi Takahashi BIOLOGICAL & PHARMACEUTICAL BULLETIN
- The rise and fall of aspirin in the primary prevention of cardiovascular disease
- (2019) Inbar Raber et al. LANCET
- Usefulness of Calculation of Cardiovascular Risk Factors to Predict Outcomes in Patients With Acute Myocardial Infarction
- (2019) Chang-Yeon Kim et al. AMERICAN JOURNAL OF CARDIOLOGY
- The predictive value of stress hyperglycemia on thrombus burden in nondiabetic patients with ST-segment elevation myocardial infarction
- (2019) Serhat Sigirci et al. BLOOD COAGULATION & FIBRINOLYSIS
- Canonical and noncanonical inflammasomes in intestinal epithelial cells
- (2019) Nathaniel Winsor et al. CELLULAR MICROBIOLOGY
- Coronary B-cell lymphoma infiltration causing myocardial infarction
- (2019) Daniel Oder et al. EUROPEAN HEART JOURNAL
- The NLRP3 Inflammasome: An Overview of Mechanisms of Activation and Regulation
- (2019) Nathan Kelley et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Inflammasomes and autoimmune and rheumatic diseases: A comprehensive review
- (2019) Jae Il Shin et al. JOURNAL OF AUTOIMMUNITY
- The role of Caspase 1 in ischemia/reperfusion injury of the myocardium.
- (2019) Ali Rauf et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Early Diagnosis of Myocardial Infarction in Patients With a History of Coronary Artery Bypass Grafting
- (2019) Luca Koechlin et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Cardiac MRI Endpoints in Myocardial Infarction Experimental and Clinical Trials
- (2019) Borja Ibanez et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Changes in conventional cardiovascular risk factors and the estimated 10-year risk of acute myocardial infarction or cerebral stroke in Sami and non-Sami populations in two population-based cross-sectional surveys: the SAMINOR Study
- (2019) Susanna Ragnhild Andersdatter Siri et al. BMJ Open
- Regulatory Mechanisms of the NLRP3 Inflammasome, a Novel Immune-Inflammatory Marker in Cardiovascular Diseases
- (2019) Na An et al. Frontiers in Immunology
- MicroRNA-155 inhibition attenuates endoplasmic reticulum stress-induced cardiomyocyte apoptosis following myocardial infarction via reducing macrophage inflammation
- (2019) Juan Hu et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- The selective NLRP3-inflammasome inhibitor MCC950 reduces myocardial fibrosis and improves cardiac remodeling in a mouse model of myocardial infarction
- (2019) Rifeng Gao et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Kanglexin, a novel anthraquinone compound, protects against myocardial ischemic injury in mice by suppressing NLRP3 and pyroptosis
- (2019) Yu Bian et al. ACTA PHARMACOLOGICA SINICA
- Imaging the Role of Inflammation in Mood and Anxiety-related Disorders
- (2018) Jennifer C. Felger Current Neuropharmacology
- Isofraxidin inhibits interleukin-1β induced inflammatory response in human osteoarthritis chondrocytes
- (2018) Jian Lin et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Targeting TLRs and the inflammasome in systemic sclerosis
- (2018) John Henderson et al. PHARMACOLOGY & THERAPEUTICS
- Control of Inflammasome Activation by Phosphorylation
- (2018) Tao Gong et al. TRENDS IN BIOCHEMICAL SCIENCES
- Selective Activation of Cannabinoid Receptor 2 Attenuates Myocardial Infarction via Suppressing NLRP3 Inflammasome
- (2018) Wen Yu et al. INFLAMMATION
- The NLRP3 inflammasome in acute myocardial infarction
- (2017) Stefano Toldo et al. Nature Reviews Cardiology
- Isofraxidin, a coumarin component improves high-fat diet induced hepatic lipid homeostasis disorder and macrophage inflammation in mice
- (2017) Jian Li et al. Food & Function
- Myocardial Infarction: Symptoms and Treatments
- (2015) Lei Lu et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- Isofraxidin protects mice from LPS challenge by inhibiting pro-inflammatory cytokines and alleviating histopathological changes
- (2015) Ling Liu et al. IMMUNOBIOLOGY
- Protective effects of Isofraxidin against lipopolysaccharide-induced acute lung injury in mice
- (2015) Xiaofeng Niu et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- NLRP3 inflammasome and its inhibitors: a review
- (2015) Bo-Zong Shao et al. Frontiers in Pharmacology
- Isofraxidin exhibited anti-inflammatory effects in vivo and inhibited TNF-α production in LPS-induced mouse peritoneal macrophages in vitro via the MAPK pathway
- (2012) Xiaofeng Niu et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Isofraxidin, a Coumarin Component from Acanthopanax senticosus, Inhibits Matrix Metalloproteinase-7 Expression and Cell Invasion of Human Hepatoma Cells
- (2010) Taisuke Yamazaki et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search